Macrophage migration inhibitory factor levels correlate with an infection in trauma patients

Young Duck Cho, Sung Hyuk Choi1, Jung Youn Kim

  • 1Department of Emergency Medicine, Korea University Guro Hdspital, Seoul-South Korea. kuedchoi@korea.ac.kr.

Abstract

Insights

Migration inhibitory factor (MIF) levels in trauma patients correlate with longer intensive care unit (ICU) stays and elevated C-reactive protein (CRP) levels. These findings suggest MIF may aid emergency physicians in assessing trauma patient severity.

Area of Science:

  • Trauma research
  • Immunology
  • Critical care medicine

Background:

  • The role of migration inhibitory factor (MIF) is established in septic shock but less understood in secondary infections post-trauma.
  • This study investigates the significance of MIF in trauma patients.

Purpose of the Study:

  • To evaluate the role and impact of MIF levels in trauma patients.
  • To explore the correlation between MIF levels and clinical outcomes.

Main Methods:

  • 116 trauma patients were enrolled and divided into groups based on MIF levels.
  • Key metrics including trauma mechanism, revised trauma score, survival rate, ICU length of stay (LOS), leukocytes, and C-reactive protein (CRP) were compared between groups.

Main Results:

  • Patients with elevated MIF levels experienced a longer ICU LOS (5.67±7.54 days) compared to those with normal MIF levels (2.09±2.26 days).
  • Elevated MIF group also showed higher CRP levels.

Conclusions:

  • MIF levels in trauma patients are associated with increased ICU length of stay and inflammation markers.
  • Measuring MIF may assist emergency physicians in predicting patient trajectories and preparing for critical scenarios.

Related Concept Videos